Medication adherence is a significant barrier to the delivery of quality health services, particularly among minority populations and the elderly. But a new study led by clinical researchers at the University of Miami Miller School of Medicine found that adherence increased 17 to 29 percent when physicians delivered glucose, blood pressure, and cholesterol-lowering medications to diabetic patients at the point of care.
“This is a simple and inexpensive strategy to improve both immediate patient satisfaction and long-term outcomes,” said Ana Palacio, M.D., M.P.H., associate professor of clinical medicine. “It removes most of the barriers to medication adherence and allows the physician to answer the patient’s questions before leaving the office. By prioritizing generic medications, the increases in adherence were not associated with higher pharmacy costs, an important consideration for providers.”
A team of researchers from the University of Miami Miller School of Medicine has shown that the I-Portal Neuro Otologic Test, which uses the head-mounted goggle that gauges eye movement through video cameras and computers, can successfully diagnose concussion with 95 percent specificity and 89 percent sensitivity.
A first-of-its-kind trial using stem cells in Alzheimer’s disease patients that is led by UHealth -- the University of Miami Health System and sponsored by Miami-based life sciences company Longeveron LLC, has received a $1 million award from the Alzheimer’s Association.
Beginning in October, South Florida’s only academic medical system, UHealth — the University of Miami Health System, will take a major step in expanding the way its pioneering research touches the lives of patients. With the launch of the UHealth Consent-To-Contact Initiative, patients will have a unique opportunity to take advantage of the many innovative therapies and treatments available through the health system.
When Marilyn K. Glassberg, M.D., professor of medicine, surgery and pediatrics, spoke at an international conference held at the Vatican, she delivered a moving account of the promising early results obtained by investigators at the University of Miami Miller School of Medicine in a small clinical trial that explored stem cell treatment in patients with idiopathic pulmonary fibrosis (IPF).
Sylvester Comprehensive Cancer Center and University of Miami Miller School of Medicine researchers Priyamvada Rai, Ph.D., associate professor of medicine/hematology and oncology, and Kerry Burnstein, Ph.D., professor of molecular and cellular pharmacology, have received a $1.15 million Idea Development Award from the Department of Defense (DOD) to investigate a novel mechanism of inhibiting incurable prostate cancer.